Literature DB >> 19735859

Radiotherapy in malignant pleural mesothelioma.

Mary Frances McAleer1, Anne S Tsao, Zhongxing Liao.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19735859     DOI： 10.1016/j.ijrobp.2009.06.037

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  11 in total

1.  The need for randomized trials in mesothelioma: let's walk the talk.

Authors:  Tom Treasure; Suresh Senan
Journal:  Oncologist       Date:  2011-02-23

2.  SEOM guidelines for the treatment of malignant pleural mesothelioma.

Authors:  Pilar Lianes; Jordi Remon; Isabel Bover; Dolores Isla
Journal:  Clin Transl Oncol       Date:  2011-08       Impact factor: 3.405

Review 3.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

4.  Radiotherapy applications of patients with malignant mesothelioma: A single center experience.

Authors:  Muge Akmansu; Ozge Petek Erpolat; Fatih Goksel; Evrim Tunc; Can Ozturk
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-09

5.  PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.

Authors:  Andrei Fodor; Claudio Fiorino; Italo Dell'Oca; Sara Broggi; Marcella Pasetti; Giovanni Mauro Cattaneo; Luigi Gianolli; Riccardo Calandrino; Nadia Gisella Di Muzio
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

6.  FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients.

Authors:  E Incerti; S Broggi; A Fodor; M Cuzzocrea; A M Samanes Gajate; P Mapelli; C Fiorino; I Dell'Oca; M Pasetti; M Cattaneo; R Calandrino; L Gianolli; N Di Muzio; Maria Picchio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-06       Impact factor: 9.236

7.  Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.

Authors:  Sukran Ulger; Eren Cetin; Serap Catli; Hilal Sarac; Diclehan Kilic; Huseyin Bora
Journal:  Technol Cancer Res Treat       Date:  2016-11-15

8.  Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.

Authors:  Stefan B Watzka; Florian Posch; Harvey I Pass; Raja M Flores; Gregory E Hannigan; David Bernhard; Michael Weber; Michael R Mueller
Journal:  Eur J Cardiothorac Surg       Date:  2012-10-07       Impact factor: 4.191

9.  Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.

Authors:  Angelo Maggio; Claudia Cutaia; Amalia Di Dia; Sara Bresciani; Anna Miranti; Matteo Poli; Elena Del Mastro; Elisabetta Garibaldi; Pietro Gabriele; Michele Stasi
Journal:  Strahlenther Onkol       Date:  2015-10-09       Impact factor: 3.621

10.  Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.

Authors:  Rea Federico; Favaretto Adolfo; Marulli Giuseppe; Spaggiari Lorenzo; DePas Tommaso Martino; Ceribelli Anna; Paccagnella Adriano; Crivellari Gino; Russo Francesca; Ceccarelli Matteo; Kazeem Gbenga; Marchi Paolo; Facciolo Francesco
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.